Hoffmann La Roche Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HOFFMANN LA ROCHE, and what generic alternatives to HOFFMANN LA ROCHE drugs are available?
HOFFMANN LA ROCHE has ten approved drugs.
There are six US patents protecting HOFFMANN LA ROCHE drugs.
There are one hundred and seventy-nine patent family members on HOFFMANN LA ROCHE drugs in forty-six countries and twenty-three supplementary protection certificates in seventeen countries.
Summary for Hoffmann La Roche
International Patents: | 179 |
US Patents: | 6 |
Tradenames: | 9 |
Ingredients: | 8 |
NDAs: | 10 |
Drugs and US Patents for Hoffmann La Roche
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hoffmann La Roche | ZELBORAF | vemurafenib | TABLET;ORAL | 202429-001 | Aug 17, 2011 | RX | Yes | Yes | 7,863,288 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Hoffmann La Roche | ZELBORAF | vemurafenib | TABLET;ORAL | 202429-001 | Aug 17, 2011 | RX | Yes | Yes | 8,470,818 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hoffmann La Roche | ZELBORAF | vemurafenib | TABLET;ORAL | 202429-001 | Aug 17, 2011 | RX | Yes | Yes | 8,143,271 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Hoffmann La Roche | ROCEPHIN | ceftriaxone sodium | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | 050585-003 | Dec 21, 1984 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Hoffmann La Roche
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Hoffmann La Roche | BONIVA | ibandronate sodium | TABLET;ORAL | 021455-001 | May 16, 2003 | 4,927,814 | ⤷ Try a Trial |
Hoffmann La Roche | BONIVA | ibandronate sodium | TABLET;ORAL | 021455-002 | Mar 24, 2005 | 7,718,634 | ⤷ Try a Trial |
Hoffmann La Roche | FORTOVASE | saquinavir | CAPSULE;ORAL | 020828-001 | Nov 7, 1997 | 6,008,228*PED | ⤷ Try a Trial |
Hoffmann La Roche | ACCUTANE | isotretinoin | CAPSULE;ORAL | 018662-002 | May 7, 1982 | 4,200,647 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for HOFFMANN LA ROCHE drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Injection | 1 mg/mL, 3 mL Vial | ➤ Subscribe | 2007-08-31 |
➤ Subscribe | Tablets | 2.5 mg and 150 mg | ➤ Subscribe | 2007-05-16 |
International Patents for Hoffmann La Roche Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
China | 102596953 | ⤷ Try a Trial |
Russian Federation | 2565071 | ⤷ Try a Trial |
South Korea | 20120101439 | ⤷ Try a Trial |
Brazil | PI0611863 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Hoffmann La Roche Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1893612 | 2012C/028 | Belgium | ⤷ Try a Trial | PRODUCT NAME: VERMURAFENIB ET SES SELS PHARMACEUTIQUEMENT ACCEPTABLES, SOUS TOUTES FORMES COUVERTES PAR LE BREVET DE BASE; AUTHORISATION NUMBER AND DATE: EU/1/12/751/001 20120221 |
1893612 | C 2012 020 | Romania | ⤷ Try a Trial | PRODUCT NAME: VEMURAFENIB SAU O SARE ACCEPTABILA FARMACEUTIC A ACESTUIA; NATIONAL AUTHORISATION NUMBER: EU/1/17/1212; DATE OF NATIONAL AUTHORISATION: 20120217; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/17/1212; DATE OF FIRST AUTHORISATION IN EEA: 20120217 |
1893612 | PA2012010 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: VEMURAFENIBUM; REGISTRATION NO/DATE: EU/1/12/751/001 20120217 |
1893612 | 28/2012 | Austria | ⤷ Try a Trial | PRODUCT NAME: VEMURAFENIB UND PHARMAZEUTISCH VERTRAEGLICHE SALZE DAVON; REGISTRATION NO/DATE: EU/1/12/751/001 (MITTEILUNG) 20120221 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.